GZMB and gastric cancer: Chen et al., reported that TIM-3 potentially promoted CD8+ T cell dysfunction in GC, manifested by decreased IFN-γ, perforin, and Granzyme B (GzmB) levels, but increased PD-1 and CTLA-4 levels (132).